Final Generic Abuse-Deterrent Opioids Guidance Coming This Year
Executive Summary
US FDA says it expects to finalize guidance by November, but more research is needed with generic development questions lingering.
You may also be interested in...
FDA's Opioid Programs: After Training, What's The Next Step?
Treatment guidelines may also appear in opioid labeling, and insurers seem to be taking the agency's advice, but will it be enough to satisfy Congress?
Abuse-Deterrent Opioid Manufacturers Want FDA To Set Conversion Deadline
US agency denied group's 2013 citizen petition, but with more abuse-deterrent products on the market, sponsors hope climate is more favorable for idea that older opioids should come off market once three similar abuse-deterrent products are available.
Abuse-Deterrent Opioid Manufacturers Want FDA To Set Conversion Deadline
US agency denied group's 2013 citizen petition, but with more abuse-deterrent products on the market, sponsors hope climate is more favorable for idea that older opioids should come off market once three similar abuse-deterrent products are available.